Exposure to hydroxyurea during pregnancy: a case series
β Scribed by Thauvin-Robinet, C; Maingueneau, C; Robert, E; Elefant, E; Guy, H; Caillot, D; Casasnovas, RO; Douvier, S; Nivelon-Chevallier, A
- Book ID
- 110054934
- Publisher
- Nature Publishing Group
- Year
- 2001
- Tongue
- English
- Weight
- 90 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We conducted a case-control study using data from the Spanish Collaborative Study of Congenital Malformations (ECEMC) on the relationship between prenatal exposure to valproic acid (VPA) and the presence of limb deficiencies in newborn infants. Among a total of 22,294 consecutive malformed infants (
A patient being treated for sickle cell disease with hydroxyurea (1 g/d) conceived, and drug treatment was discontinued at nine weeks gestational age. The pregnancy and delivery were complicated by vaso-oclusive crises. A healthy male infant was born at 39 weeks with no evidence of congenital malfor